190 related articles for article (PubMed ID: 38478773)
1. Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline.
Braun IM; Bohlke K; Abrams DI; Anderson H; Balneaves LG; Bar-Sela G; Bowles DW; Chai PR; Damani A; Gupta A; Hallmeyer S; Subbiah IM; Twelves C; Wallace MS; Roeland EJ
J Clin Oncol; 2024 May; 42(13):1575-1593. PubMed ID: 38478773
[TBL] [Abstract][Full Text] [Related]
2. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.
Smith LA; Azariah F; Lavender VT; Stoner NS; Bettiol S
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009464. PubMed ID: 26561338
[TBL] [Abstract][Full Text] [Related]
4. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
[TBL] [Abstract][Full Text] [Related]
5. Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer.
Alderman B; Hui D; Mukhopadhyay S; Bouleuc C; Case AA; Amano K; Crawford GB; de Feo G; Sbrana A; Tanco K; To J; Garsed J; Davis M
Support Care Cancer; 2022 Dec; 31(1):39. PubMed ID: 36525085
[TBL] [Abstract][Full Text] [Related]
6. Cannabis for the treatment of ulcerative colitis.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
[TBL] [Abstract][Full Text] [Related]
7. Understanding Cannabis-Based Therapeutics in Sports Medicine.
Maurer GE; Mathews NM; Schleich KT; Slayman TG; Marcussen BL
Sports Health; 2020; 12(6):540-546. PubMed ID: 32936058
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids for symptom management in children with cancer: A systematic review and meta-analysis.
Chhabra M; Ben-Eltriki M; Paul A; Lê ML; Herbert A; Oberoi S; Bradford N; Bowers A; Rassekh SR; Kelly LE
Cancer; 2023 Nov; 129(22):3656-3670. PubMed ID: 37635461
[TBL] [Abstract][Full Text] [Related]
10. Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline Q&A.
Braun IM; Bohlke K; Roeland EJ
JCO Oncol Pract; 2024 Jun; 20(6):767-770. PubMed ID: 38478793
[TBL] [Abstract][Full Text] [Related]
11. Cannabis for the treatment of Crohn's disease.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].
Volz MS; Siegmund B; Häuser W
Schmerz; 2016 Feb; 30(1):37-46. PubMed ID: 26809974
[TBL] [Abstract][Full Text] [Related]
13. Medical cannabis use in oncology and associated outcomes: A scoping review.
Valente AC; Lopes LPN; Matheus ME
J Oncol Pharm Pract; 2024 Jun; 30(4):737-751. PubMed ID: 38477532
[TBL] [Abstract][Full Text] [Related]
14. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
Wang L; Hong PJ; May C; Rehman Y; Oparin Y; Hong CJ; Hong BY; AminiLari M; Gallo L; Kaushal A; Craigie S; Couban RJ; Kum E; Shanthanna H; Price I; Upadhye S; Ware MA; Campbell F; Buchbinder R; Agoritsas T; Busse JW
BMJ; 2021 Sep; 374():n1034. PubMed ID: 34497047
[TBL] [Abstract][Full Text] [Related]
15. Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology.
Turgeman I; Bar-Sela G
Expert Opin Investig Drugs; 2019 Mar; 28(3):285-296. PubMed ID: 30572744
[TBL] [Abstract][Full Text] [Related]
16. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
17. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.
Botsford SL; Yang S; George TP
Am J Addict; 2020 Jan; 29(1):9-26. PubMed ID: 31577377
[TBL] [Abstract][Full Text] [Related]
18. Medical Cannabinoids in Children and Adolescents: A Systematic Review.
Wong SS; Wilens TE
Pediatrics; 2017 Nov; 140(5):. PubMed ID: 29061872
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.
Tafelski S; Häuser W; Schäfer M
Schmerz; 2016 Feb; 30(1):14-24. PubMed ID: 26787227
[TBL] [Abstract][Full Text] [Related]
20. Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline.
Busse JW; Vankrunkelsven P; Zeng L; Heen AF; Merglen A; Campbell F; Granan LP; Aertgeerts B; Buchbinder R; Coen M; Juurlink D; Samer C; Siemieniuk RAC; Kumar N; Cooper L; Brown J; Lytvyn L; Zeraatkar D; Wang L; Guyatt GH; Vandvik PO; Agoritsas T
BMJ; 2021 Sep; 374():n2040. PubMed ID: 34497062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
